US6861212B1
(en)
|
1987-11-18 |
2005-03-01 |
Chiron Corporation |
NANBV diagnostics and vaccines
|
US5683864A
(en)
*
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
HU216017B
(hu)
*
|
1987-11-18 |
1999-04-28 |
Chiron Corp. |
Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
|
US6171782B1
(en)
|
1987-11-18 |
2001-01-09 |
Chiron Corporation |
Antibody compositions to HCV and uses thereof
|
US5714596A
(en)
*
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
US5350671A
(en)
*
|
1987-11-18 |
1994-09-27 |
Chiron Corporation |
HCV immunoassays employing C domain antigens
|
US5698390A
(en)
*
|
1987-11-18 |
1997-12-16 |
Chiron Corporation |
Hepatitis C immunoassays
|
US5712088A
(en)
*
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
US5191064A
(en)
*
|
1988-09-30 |
1993-03-02 |
The Research Foundation For Microbial Diseases (Osaka University) |
Non-a, non-b hepatitis virus antigen peptide
|
JP2696116B2
(ja)
*
|
1988-09-30 |
1998-01-14 |
財団法人阪大微生物病研究会 |
非a非b肝炎患者の血清と抗原抗体反応するペプチド、及び該ペプチドをコードするdna
|
JPH02167081A
(ja)
*
|
1988-12-21 |
1990-06-27 |
Tetsuo Nakamura |
非A非B型肝炎ウイルスゲノムRNA、cDNAおよびウイルス抗原蛋白質
|
WO1990011089A1
(en)
*
|
1989-03-17 |
1990-10-04 |
Chiron Corporation |
Nanbv diagnostics and vaccines
|
US6027729A
(en)
*
|
1989-04-20 |
2000-02-22 |
Chiron Corporation |
NANBV Diagnostics and vaccines
|
MC2188A1
(fr)
*
|
1989-05-18 |
1992-09-16 |
Chiron Corp |
Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c
|
JPH0330676A
(ja)
*
|
1989-06-28 |
1991-02-08 |
Sanwa Kagaku Kenkyusho Co Ltd |
非a非b型肝炎ウイルスのdna、そのクローン及びこれらの調製法
|
EP0416725A3
(en)
*
|
1989-07-14 |
1991-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
|
DK0414475T3
(da)
*
|
1989-08-25 |
1998-02-09 |
Chiron Corp |
Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
|
CA2065287C
(en)
*
|
1989-09-15 |
1999-12-21 |
Tatsuo Miyamura |
New hcv isolates
|
US5372928A
(en)
*
|
1989-09-15 |
1994-12-13 |
Chiron Corporation |
Hepatitis C virus isolates
|
FR2654113A1
(fr)
*
|
1989-11-09 |
1991-05-10 |
Pasteur Institut |
Procede de diagnostic de virus appartenant a la famille des flaviviridae.
|
AU642942B2
(en)
*
|
1989-12-18 |
1993-11-04 |
Wellcome Foundation Limited, The |
Viral agent
|
US7166287B1
(en)
|
1989-12-18 |
2007-01-23 |
Glaxo Wellcome Inc. |
Viral agent
|
AU638304B2
(en)
*
|
1989-12-22 |
1993-06-24 |
Abbott Laboratories |
Hepatitis c assay
|
US5308750A
(en)
*
|
1989-12-22 |
1994-05-03 |
Abbott Laboratories |
Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
|
EP0435229A1
(en)
*
|
1989-12-27 |
1991-07-03 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
|
CA2036022A1
(en)
*
|
1990-02-09 |
1991-08-10 |
Tetsuo Nakamura |
Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US5106726A
(en)
*
|
1990-02-16 |
1992-04-21 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV
|
US5639594A
(en)
*
|
1990-02-16 |
1997-06-17 |
United Biomedical, Inc. |
Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
KR940000755B1
(ko)
*
|
1990-02-16 |
1994-01-29 |
유나이티드 바이오메디칼 인코오포레이티드 |
Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
|
US5747239A
(en)
*
|
1990-02-16 |
1998-05-05 |
United Biomedical, Inc. |
Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
|
US5582968A
(en)
*
|
1990-02-16 |
1996-12-10 |
United Biomedical, Inc. |
Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
|
EP0445801A3
(en)
*
|
1990-03-08 |
1992-07-01 |
Kuraray Co., Ltd. |
Peptide and its use
|
EP0447984A1
(en)
*
|
1990-03-20 |
1991-09-25 |
Abbott Laboratories |
Hyperimmune globulin against hepatitis C virus and method for making same
|
JPH0436185A
(ja)
*
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
WO1991014779A1
(en)
*
|
1990-03-28 |
1991-10-03 |
Mitsui Toatsu Chemicals, Incorporated |
Diagnostic for hepatitis virus
|
US6194140B1
(en)
*
|
1990-04-04 |
2001-02-27 |
Chiron Corporation |
HCV NS3 protein fragments having helicase activity and improved solubility
|
US5712087A
(en)
*
|
1990-04-04 |
1998-01-27 |
Chiron Corporation |
Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
|
PL172133B1
(pl)
*
|
1990-04-04 |
1997-08-29 |
Chiron Corp |
Sposób tworzenia kombinacji antygenów wirusowego zapalenia watroby typu C (HCV) i sposób wykrywania przeciwcial przeciw wirusowemu zapaleniu watroby typu C (HCV) PL PL PL PL PL PL
|
ES2219637T3
(es)
*
|
1990-04-04 |
2004-12-01 |
Chiron Corporation |
Proteasa del virus de la hepatitis c.
|
JPH05506230A
(ja)
*
|
1990-04-06 |
1993-09-16 |
ジーンラブス テクノロジイズ インコーポレイテッド |
C型肝炎ウイルスエピトープ
|
JP3050395B2
(ja)
*
|
1990-06-12 |
2000-06-12 |
国立感染症研究所長 |
C型肝炎ウイルス抗原ポリペプチド、その産生方法および抗体の検出方法
|
EP0461863A1
(en)
*
|
1990-06-12 |
1991-12-18 |
Immuno Japan Inc. |
Oligonucleotide primers, and their application for high-fidelity detection of non-A, non-B hepatitis virus
|
EP0933426A1
(en)
*
|
1990-06-25 |
1999-08-04 |
The Research Foundation for Microbial Diseases of Osaka University |
Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
|
NZ238681A
(en)
*
|
1990-06-25 |
1992-03-26 |
Univ Osaka Res Found |
Non-a, non-b hepatitis virus particles and their production
|
US5747339A
(en)
*
|
1990-06-25 |
1998-05-05 |
Research Foundation For Microbial Diseases Of Osaka |
Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
|
EP0551275B1
(en)
*
|
1990-06-30 |
1994-12-21 |
Akzo Nobel N.V. |
Non-a non-b sequences
|
KR0181517B1
(ko)
*
|
1990-07-09 |
1999-04-01 |
나까하라 노부유끼 |
비-에이 비-비형 간염-특이 항원 및 간염 진단에서 그의 용도
|
ATE150086T1
(de)
*
|
1990-07-11 |
1997-03-15 |
Shionogi & Co |
Cdns-sequenz und detektion des hepatitis c-virus
|
WO1992001714A1
(en)
*
|
1990-07-24 |
1992-02-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Non-a non-b hepatitis virus antigen
|
CA2047792C
(en)
*
|
1990-07-26 |
2002-07-02 |
Chang Y. Wang |
Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
|
CA2049679C
(en)
*
|
1990-08-24 |
2005-06-21 |
Sushil G. Devare |
Hepatitis c assay utilizing recombinant antigens
|
KR920004577A
(ko)
*
|
1990-08-24 |
1992-03-27 |
원본미기재 |
단백질 합성의 cks 방법
|
US6172189B1
(en)
*
|
1990-08-24 |
2001-01-09 |
Abbott Laboratories |
Hepatitis C assay utilizing recombinant antigens
|
ATE346302T1
(de)
*
|
1990-08-25 |
2006-12-15 |
Bioprocess Pty Ltd |
Nicht-a, nicht-b hepatitis virus antigen, und diagnostische verfahren.
|
US7863008B2
(en)
|
1990-08-25 |
2011-01-04 |
Bioprocess Pty Ltd. |
Method for detecting NANBV associated seroconversion
|
EP0552297A1
(en)
*
|
1990-10-12 |
1993-07-28 |
Abbott Laboratories |
Hepatitis c virus antibody
|
JP3549201B2
(ja)
*
|
1990-10-24 |
2004-08-04 |
中外製薬株式会社 |
非a非b型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
|
DE59109221D1
(de)
*
|
1990-11-03 |
2001-11-15 |
Dade Behring Marburg Gmbh |
HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
|
DE4112743C2
(de)
*
|
1991-04-19 |
2000-01-13 |
Dade Behring Marburg Gmbh |
Synthetische Core-Peptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
DE4121431A1
(de)
*
|
1991-06-28 |
1993-01-07 |
Behringwerke Ag |
Synthetische core-peptide zur bestimmung von hcv-antikoerpern und hcv-antigenen, mittel dazu und ihre verwendung in diesen nachweis-verfahren
|
DE4120281C2
(de)
*
|
1991-06-19 |
1999-11-25 |
Dade Behring Marburg Gmbh |
Immunchemisches Verfahren zum gleichzeitigen Nachweis von mehreren verschiedenen Antikörperspezifitäten, Peptidmischungen und Test dazu
|
DE4034982C2
(de)
*
|
1990-11-03 |
1999-12-23 |
Dade Behring Marburg Gmbh |
Synthetische Polypeptide zur Bestimmung von HCV-Antikörpern und HCV-Antigenen, Mittel dazu und ihre Verwendung in diesen Nachweis-Verfahren
|
US5753430A
(en)
*
|
1990-11-07 |
1998-05-19 |
Abbott Laboratories |
Monoclonal antibodies to hepatitis C virus and method for using same
|
DE69131046T2
(de)
*
|
1990-11-07 |
1999-10-21 |
Abbott Lab |
Monoklonale antikörper gegen den hepatitis c-virus und verfahren diese zu benutzen
|
US6274148B1
(en)
*
|
1990-11-08 |
2001-08-14 |
Chiron Corporation |
Hepatitis C virus asialoglycoproteins
|
SK285623B6
(sk)
*
|
1990-11-08 |
2007-05-03 |
Chiron Corporation |
Spôsob produkcie asialoglykoproteínu hepatitis C vírusu
|
EP0485209A1
(en)
*
|
1990-11-08 |
1992-05-13 |
Immuno Japan Inc. |
Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
|
WO1992009634A1
(en)
*
|
1990-11-29 |
1992-06-11 |
Toray Industries, Incorporated |
Non-a non-b hepatitis virus antigen protein
|
CA2056646A1
(en)
*
|
1990-11-29 |
1992-05-30 |
Shunji Mishiro |
Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents
|
US6007982A
(en)
*
|
1990-12-14 |
1999-12-28 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
DK0644202T3
(da)
*
|
1990-12-14 |
1997-09-15 |
Innogenetics Nv |
Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
|
US5910404A
(en)
|
1990-12-14 |
1999-06-08 |
Innogenetics N.V. |
Synthetic antigens for the detection of antibodies to hepatitis C virus
|
KR930703613A
(ko)
*
|
1991-01-25 |
1993-11-30 |
챨스 엠. 브록 |
시료 희석물중 과산화물 디스뮤타제의 용도
|
ES2118129T3
(es)
*
|
1991-01-31 |
1998-09-16 |
Abbott Lab |
Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
|
WO1992017612A1
(en)
*
|
1991-03-26 |
1992-10-15 |
Baxter Diagnostics Inc. |
Assay for non-a non-b hepatitis
|
US5574132A
(en)
*
|
1991-04-05 |
1996-11-12 |
Biochem Immunosystems Inc. |
Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
|
EP0516270A3
(en)
*
|
1991-04-10 |
1993-06-23 |
Immuno Japan Inc. |
Non-a, non-b hepatitis virus related antigen, antibody, detection systems, polynucleotides and polypeptides
|
WO1992018532A1
(en)
*
|
1991-04-17 |
1992-10-29 |
Eisai Co., Ltd. |
Rna, dna and virus antigen protein of non-a non-b hepatitis virus
|
EP0510952A1
(en)
*
|
1991-04-26 |
1992-10-28 |
Immuno Japan Inc. |
Oligonucleotide primers and their application for high-fidelity detection of non-a, non-b hepatitis virus
|
ATE252154T1
(de)
*
|
1991-05-08 |
2003-11-15 |
Chiron Corp |
Genomische hcv-sequenzen für diagnostik und therapie
|
ES2040615B1
(es)
*
|
1991-05-27 |
1994-05-16 |
Nebrda Fernando Javi Bartolome |
Procedimiento para el aislamiento y clonaje de cdnas derivados del virus c de la hepatitis.
|
FR2677372B1
(fr)
*
|
1991-06-06 |
1994-11-10 |
Pasteur Institut |
Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
|
AT405053B
(de)
*
|
1991-06-10 |
1999-05-25 |
Lucky Ltd |
Hepatitis-c-diagnosemittel und -impfstoffe
|
CA2070952A1
(en)
*
|
1991-06-11 |
1992-12-12 |
Makoto Seki |
Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
|
EP0591431B1
(en)
*
|
1991-06-24 |
2002-12-11 |
Chiron Corporation |
Hepatitis c virus (hcv) polypeptides
|
DE4209215A1
(de)
|
1991-07-04 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Hcv peptidantigene und verfahren zur bestimmung von hcv
|
AU2513592A
(en)
*
|
1991-08-21 |
1993-03-16 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens to ns1
|
AU2492792A
(en)
*
|
1991-08-21 |
1993-03-16 |
Abbott Laboratories |
Hepatitis c assay utilizing recombinant antigens from ns5 region
|
JPH06510188A
(ja)
*
|
1991-08-21 |
1994-11-17 |
アボツト・ラボラトリーズ |
推定hcv ns5タンパクに対するモノクローナル抗体およびそれを使用する方法
|
DE69223562T2
(de)
*
|
1991-08-27 |
1998-06-04 |
Hoffmann La Roche |
Verfahren und Reagenzien zum Nachweis von Hepatitis C
|
RU2212899C2
(ru)
*
|
1991-09-13 |
2003-09-27 |
Чирон Корпорейшн |
Hcv иммунореактивные полипептидные композиции
|
ZA927837B
(en)
*
|
1991-10-15 |
1994-03-11 |
Akzo Nv |
Monoclonal antibodiesto hepatitis C virus
|
WO1993009253A1
(en)
*
|
1991-11-07 |
1993-05-13 |
Baxter Diagnostics Inc. |
Epitope mapping ot the c33c region of hcv
|
JPH05130874A
(ja)
*
|
1991-11-07 |
1993-05-28 |
Sanwa Kagaku Kenkyusho Co Ltd |
ヒトC型肝炎ウイルスのcDNA、そのクローン及びこれらの利用法
|
US5763159A
(en)
*
|
1991-11-21 |
1998-06-09 |
Common Services Agency |
Hepatitis-C virus testing
|
ES2210235T3
(es)
*
|
1992-01-31 |
2004-07-01 |
Abbott Laboratories |
Sistemas de expresion de mamiferos para proteinas de hcv.
|
US6709828B1
(en)
|
1992-03-06 |
2004-03-23 |
N.V. Innogenetics S.A. |
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
|
US6667387B1
(en)
|
1996-09-30 |
2003-12-23 |
N.V. Innogenetics S.A. |
HCV core peptides
|
MY111880A
(en)
*
|
1992-03-27 |
2001-02-28 |
Smithkline Beecham Biologicals S A |
Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
|
US6620414B2
(en)
|
1992-03-27 |
2003-09-16 |
Smithkline Beecham Biologicals (S.A.) |
Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
|
US5866139A
(en)
*
|
1992-06-04 |
1999-02-02 |
Institut Pasteur |
Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
|
US5980899A
(en)
*
|
1992-06-10 |
1999-11-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
|
UA39944C2
(uk)
|
1992-07-07 |
2001-07-16 |
Чірон Корпорейшн |
Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
|
US5859230A
(en)
*
|
1992-07-30 |
1999-01-12 |
Genelabs Technologies, Inc. |
Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
|
DE4240980A1
(de)
*
|
1992-08-07 |
1994-02-10 |
Boehringer Mannheim Gmbh |
HCV Peptidantigene und Verfahren zur Bestimmung von HCV
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6995146B2
(en)
|
1992-09-10 |
2006-02-07 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
DE69330372T2
(de)
|
1992-09-10 |
2002-03-14 |
Isis Pharmaceuticals Inc |
ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
US6057093A
(en)
*
|
1992-09-28 |
2000-05-02 |
Chiron Corporation |
Methods and compositions for controlling translation of HCV proteins
|
CN1059928C
(zh)
*
|
1992-09-29 |
2000-12-27 |
天津普生生物科技有限公司 |
利用大肠杆菌制备可用来检验c型肝炎之抗原蛋白的方法
|
US6153378A
(en)
*
|
1992-10-16 |
2000-11-28 |
Bionova Corporation |
Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
|
JP2778886B2
(ja)
*
|
1992-10-16 |
1998-07-23 |
エバーニュー バイオテック インコーポレイティド |
C型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
|
EP0593291A3
(en)
*
|
1992-10-16 |
1995-03-15 |
Evernew Biotech Inc |
Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
|
JPH06153959A
(ja)
*
|
1992-10-16 |
1994-06-03 |
Evernew Biotec Inc |
C型肝炎ウィルスの非構造タンパク質及びそれを用いての診断方法及びキット
|
EP0672065A1
(en)
*
|
1992-12-07 |
1995-09-20 |
Akzo Nobel N.V. |
Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
|
KR950704354A
(ko)
*
|
1992-12-07 |
1995-11-20 |
에프.쥐.엠, 헤르만스 페.카.브론스 |
씨(c)형 간염 바이러스(hcv)씨(c)33 영역 유래의 펩티드, 이에 대한 항체 및 씨(c)형 간염 바이러스를 검출하는 방법(peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv)
|
AU6769594A
(en)
*
|
1993-04-22 |
1994-11-08 |
Genelabs Technologies, Inc. |
Hepatitis c virus immunodiagnostic antigens and antibodies
|
ATE551423T1
(de)
*
|
1993-04-27 |
2012-04-15 |
Innogenetics Nv |
Sequenzen von hepatitis c virus-genotypen sowie ihre verwendungen als therapeutika und diagnostika
|
AU695259B2
(en)
|
1993-05-05 |
1998-08-13 |
Common Services Agency |
Hepatitis-C virus type 4, 5 and 6
|
RO115471B1
(ro)
|
1993-05-10 |
2000-02-28 |
Chiron Corp Emeryville |
Metoda pentru stabilirea unuia sau a mai multor tipuri de virus al hepatitei c
|
DE69433160T2
(de)
|
1993-05-12 |
2004-07-08 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region
|
WO1995011918A1
(fr)
*
|
1993-10-29 |
1995-05-04 |
Srl, Inc. |
Compose peptidique antigenique et methode de dosage immunologique
|
US5610009A
(en)
*
|
1994-01-28 |
1997-03-11 |
Abbott Laboratories |
Mammalian expression systems for hepatitis C virus envelope genes
|
US6558898B1
(en)
|
1994-02-14 |
2003-05-06 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6051374A
(en)
*
|
1994-02-14 |
2000-04-18 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6451578B1
(en)
|
1994-02-14 |
2002-09-17 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
|
US6156495A
(en)
*
|
1994-02-14 |
2000-12-05 |
Abbott Laboratories |
Hepatitis GB virus recombinant proteins and uses thereof
|
US5981172A
(en)
*
|
1994-02-14 |
1999-11-09 |
Abbott Laboratories |
Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
|
US5843450A
(en)
*
|
1994-02-14 |
1998-12-01 |
Abbott Laboratories |
Hepatitis GB Virus synthetic peptides and uses thereof
|
US6720166B2
(en)
|
1994-02-14 |
2004-04-13 |
Abbott Laboratories |
Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
|
US5874563A
(en)
*
|
1994-05-20 |
1999-02-23 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
US5824507A
(en)
*
|
1994-05-20 |
1998-10-20 |
Genelabs Technologies, Inc. |
Hepatitis G virus and molecular cloning thereof
|
JP3217600B2
(ja)
|
1994-07-12 |
2001-10-09 |
株式会社先端生命科学研究所 |
非a非b型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
|
DE69534296T2
(de)
|
1994-07-29 |
2006-04-27 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Sezernierter E1/E2-Komplex des Hepatitis C-Virus, des aus C-terminal verkürzten Polypeptiden E1 und E2 erhalten ist
|
PT773957E
(pt)
*
|
1994-07-29 |
2005-11-30 |
Chiron Corp |
Polipeptidos truncados e1 e e2 de hepatite c inovadores, e metodos de obtencao dos mesmos
|
DE4428705A1
(de)
|
1994-08-12 |
1996-02-15 |
Boehringer Mannheim Gmbh |
Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
|
US5955318A
(en)
*
|
1995-08-14 |
1999-09-21 |
Abbott Laboratories |
Reagents and methods useful for controlling the translation of hepatitis GBV proteins
|
US5709997A
(en)
*
|
1995-08-14 |
1998-01-20 |
Abbott Laboratories |
Nucleic acid detection of hepatitis GB virus
|
US5807670A
(en)
*
|
1995-08-14 |
1998-09-15 |
Abbott Laboratories |
Detection of hepatitis GB virus genotypes
|
US6127116A
(en)
*
|
1995-08-29 |
2000-10-03 |
Washington University |
Functional DNA clone for hepatitis C virus (HCV) and uses thereof
|
GB9517926D0
(en)
|
1995-09-01 |
1995-11-01 |
Biocine Spa |
Binding protein
|
US5851758A
(en)
*
|
1995-10-25 |
1998-12-22 |
Childrens Research Institute |
Cytopathic replication of hepatitis C virus in a new cell line
|
US5837442A
(en)
|
1995-11-29 |
1998-11-17 |
Roche Molecular Systems, Inc. |
Oligonucleotide primers for amplifying HCV nucleic acid
|
US5851759A
(en)
*
|
1996-04-19 |
1998-12-22 |
Chiron Corporation |
Heteroduplex tracking assay (HTA) for genotyping HCV
|
JP3715027B2
(ja)
|
1996-05-07 |
2005-11-09 |
シスメックス株式会社 |
C型肝炎ウイルス感染症診断薬
|
CU22642A1
(es)
*
|
1996-12-12 |
2000-12-22 |
Ct Ingenieria Genetica Biotech |
Secuencia de adnc derivadas del genoma del virus de la hepatitis c y su uso
|
US7049428B1
(en)
|
1998-03-04 |
2006-05-23 |
Washington University |
HCV variants
|
US7338759B1
(en)
|
1997-03-04 |
2008-03-04 |
Washington University |
HCV variants
|
DE69841015D1
(de)
|
1997-05-06 |
2009-09-10 |
Novartis Vaccines & Diagnostic |
Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
|
US6010848A
(en)
*
|
1997-07-02 |
2000-01-04 |
Smithkline Beecham Corporation |
Screening methods using an atpase protein from hepatitis C virus
|
US6153392A
(en)
*
|
1997-07-30 |
2000-11-28 |
Bionova Corporation |
Devices and methods comprising an HBcAg from hepatitis B virus
|
WO1999018198A1
(en)
|
1997-10-06 |
1999-04-15 |
Chiron S.P.A. |
Hepatitis c receptor protein cd81
|
EP1029052B1
(en)
|
1997-11-06 |
2010-08-04 |
Novartis Vaccines and Diagnostics S.r.l. |
Neisserial antigens
|
DE69838513T2
(de)
|
1997-12-11 |
2008-07-03 |
Smithkline Beecham Corp. |
Verkürztes hepatitis-c-virus protein nsb5 und methoden, um antivirale substanzen zu identifizieren
|
DE69941567D1
(de)
|
1998-01-14 |
2009-12-03 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
ES2294629T3
(es)
|
1998-05-01 |
2008-04-01 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenos de neisseria y composiciones.
|
CA2689696C
(en)
|
1999-02-26 |
2013-08-06 |
Novartis Vaccines And Diagnostics, Inc. |
Microemulsions with adsorbed macromolecules and microparticles
|
AU4673099A
(en)
|
1999-02-26 |
2000-09-14 |
Chiron Corporation |
Use of bioadhesives and adjuvants for the mucosal delivery of antigens
|
ES2397918T3
(es)
|
1999-04-30 |
2013-03-12 |
Novartis Vaccines And Diagnostics S.R.L. |
Antígenos Neisseriales conservados
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
AU6226100A
(en)
*
|
1999-07-19 |
2001-04-24 |
Epimmune, Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
ES2564463T3
(es)
|
1999-10-29 |
2016-03-22 |
Glaxosmithkline Biologicals S.A. |
Péptidos antigénicos de Neisseriales
|
US7196066B1
(en)
|
1999-11-03 |
2007-03-27 |
Powderject Vaccines, Inc. |
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
|
AU5442501A
(en)
*
|
1999-12-01 |
2001-07-09 |
Chiron Corporation |
Eliciting HCV-specific antibodies
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
CA2405521C
(en)
|
2000-04-05 |
2010-06-29 |
Schering Corporation |
Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
|
BR0110104A
(pt)
|
2000-04-19 |
2003-01-07 |
Schering Corp |
Inibidores de ns-3 serina rotease macrocìclica do vìrus da hepatite c compreendendo porções de alquil e aril alanina p2
|
MXPA02012424A
(es)
*
|
2000-06-15 |
2003-04-25 |
Chiron Corp |
Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.
|
EP1829891B1
(en)
*
|
2000-06-15 |
2012-12-26 |
Novartis Vaccines and Diagnostics, Inc. |
Immunoassays for Anti-HCV Antibodies
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
JP4298289B2
(ja)
|
2000-07-21 |
2009-07-15 |
シェーリング コーポレイション |
C型肝炎ウイルスのns3−セリンプロテアーゼ阻害剤としての新規ペプチド
|
PL365695A1
(en)
|
2000-07-21 |
2005-01-10 |
|
Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
RU2286172C2
(ru)
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
CA2419418A1
(en)
*
|
2000-08-17 |
2002-02-21 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
EP2284182A1
(en)
|
2000-10-27 |
2011-02-16 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups A and B
|
AR031905A1
(es)
|
2000-12-12 |
2003-10-08 |
Schering Corp |
Peptidos diarilicos como inhibidores de ns3-serina proteasa en hepatitis de virus c
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
EP2305299B1
(en)
|
2001-05-31 |
2017-03-01 |
GlaxoSmithKline Biologicals SA |
Chimeric alphavirus replicon particles
|
US7196183B2
(en)
|
2001-08-31 |
2007-03-27 |
Innogenetics N.V. |
Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
EP2335723A1
(en)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisation against chlamydia trachomatis
|
EP1467989B1
(en)
|
2002-01-23 |
2009-09-23 |
Schering Corporation |
Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
|
EP1531796B1
(en)
|
2002-02-20 |
2016-09-28 |
GlaxoSmithKline Biologicals SA |
Microparticles with adsorbed polypeptide-containing molecules
|
WO2003077729A2
(en)
|
2002-03-11 |
2003-09-25 |
Carol Holland-Staley |
Methods and compositions for identifying and characterizing hepatitis c
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
CA2485829A1
(en)
|
2002-05-24 |
2003-12-04 |
Peng Luan |
Methods and constructs for high yield expression of clostripain
|
NZ538711A
(en)
|
2002-09-09 |
2007-01-26 |
Chiron Corp |
Antigen/antibody/antigen sandwich assays for detecting hepatitis C virus infections
|
US7927840B2
(en)
|
2006-09-11 |
2011-04-19 |
Gen Probe Incorporated |
Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
|
EP1583949B1
(en)
|
2002-10-16 |
2015-06-17 |
Gen-Probe Incorporated |
Compositions and methods for detecting west nile virus
|
CA2511512C
(en)
|
2002-12-27 |
2013-10-29 |
Chiron Corporation |
Immunogenic compositions containing phospholipid
|
MXPA05008342A
(es)
|
2003-02-06 |
2006-02-28 |
Cerus Corp |
Listeria atenuada para la entrada a las celulas no fagociticas, vacunas que comprenden la listeria, y metodos de uso de las mismas.
|
AU2004224425B2
(en)
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
JP4527722B2
(ja)
|
2003-08-26 |
2010-08-18 |
シェーリング コーポレイション |
C型肝炎ウイルスの新規のペプチド模倣性ns3−セリンプロテアーゼインヒビター
|
ES2596753T3
(es)
|
2003-08-29 |
2017-01-11 |
Fujirebio Europe N.V. |
Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
|
CA2539789A1
(en)
|
2003-09-22 |
2005-03-31 |
Green Peptide Co., Ltd. |
Peptide originating in hepatitis c virus
|
TWI280964B
(en)
|
2003-09-26 |
2007-05-11 |
Schering Corp |
Macrocyclic inhibitors of hepatitis C virus NS3 serine protease
|
BRPI0415373A
(pt)
*
|
2003-10-14 |
2006-12-12 |
Intermune Inc |
ácidos carboxìlicos macrocìclicos e acilsulfonamidas como inibidores de replicação de hcv
|
WO2005051980A1
(en)
|
2003-11-20 |
2005-06-09 |
Schering Corporation |
Depeptidized inhibitors of hepatitis c virus ns3 protease
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
DE602005015093D1
(de)
|
2004-02-27 |
2009-08-06 |
Schering Corp |
Neue verbindungen als inhibitoren der ns3-serinprotease des hepatitis-c-virus
|
CN1946692A
(zh)
|
2004-02-27 |
2007-04-11 |
先灵公司 |
作为丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的3,4-(环戊基)-稠合的脯氨酸化合物
|
AU2005222055A1
(en)
|
2004-02-27 |
2005-09-22 |
Schering Corporation |
Compounds as inhibitors of hepatitis C virus NS3 serine protease
|
TW200536528A
(en)
|
2004-02-27 |
2005-11-16 |
Schering Corp |
Novel inhibitors of hepatitis C virus NS3 protease
|
US7399749B2
(en)
|
2004-05-20 |
2008-07-15 |
Schering Corporation |
Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
WO2006026352A1
(en)
|
2004-08-27 |
2006-03-09 |
Schering Corporation |
Acylsulfonamide compounds as inhibitors of hepatitis c virus ns3 serine protease
|
WO2006024020A2
(en)
|
2004-08-27 |
2006-03-02 |
Novartis Vaccines And Diagnostics Inc. |
Hcv non-structural protein mutants and uses thereof
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
WO2006116423A2
(en)
|
2005-04-26 |
2006-11-02 |
Eisai Co., Ltd |
Compositions and methods for cancer immunotherapy
|
CA2618429A1
(en)
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
AU2006252553B2
(en)
|
2005-06-02 |
2012-03-29 |
Merck Sharp & Dohme Corp. |
Combination of HCV protease inhibitors with a surfactant
|
US8119602B2
(en)
|
2005-06-02 |
2012-02-21 |
Schering Corporation |
Administration of HCV protease inhibitors in combination with food to improve bioavailability
|
WO2007053245A2
(en)
|
2005-09-20 |
2007-05-10 |
Immunivest Corporation |
Methods and composition to generate unique sequence dna probes, iabeling of dna probes and the use of these probes
|
WO2007135707A1
(ja)
|
2006-05-18 |
2007-11-29 |
Nichia Corporation |
樹脂成形体及び表面実装型発光装置並びにそれらの製造方法
|
PL2054431T3
(pl)
|
2006-06-09 |
2012-07-31 |
Novartis Ag |
Konformery adhezyn bakteryjnych
|
EP2185195A2
(en)
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen platform
|
NZ599777A
(en)
|
2007-11-07 |
2013-09-27 |
Celldex Therapeutics Inc |
Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
|
WO2009076158A1
(en)
|
2007-12-07 |
2009-06-18 |
Novartis Ag |
Compositions for inducing immune responses
|
CN101939443B
(zh)
|
2008-02-08 |
2014-01-29 |
Ambrx公司 |
经修饰瘦素多肽和其用途
|
WO2009130588A2
(en)
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
US20110287055A1
(en)
|
2008-05-19 |
2011-11-24 |
Aduro Biotech |
Compositions comprising prfa* mutant listeria and mehtods of use thereof
|
WO2010036964A2
(en)
|
2008-09-26 |
2010-04-01 |
Ambrx Inc. |
Modified animal erythropoietin polypeptides and their uses
|
EP2376078A2
(en)
|
2008-12-12 |
2011-10-19 |
Schering Corporation |
Deuterated compounds as hepatitis c virus (hcv) inhibitors
|
JP2012519724A
(ja)
|
2009-03-09 |
2012-08-30 |
ヘンルイ ウイルリアム |
シグナルペプチドを担体として有する細菌毒素とのハプテン‐担体抱合体及び免疫原性組成物としてのその使用
|
AU2010253791A1
(en)
|
2009-05-29 |
2011-11-24 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C
|
EP2451475A2
(en)
|
2009-07-06 |
2012-05-16 |
Novartis AG |
Self replicating rna molecules and uses thereof
|
WO2011066241A1
(en)
|
2009-11-25 |
2011-06-03 |
Schering Corporation |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
CA2788155C
(en)
|
2010-01-27 |
2018-04-24 |
AB Pharma Ltd. |
Polyheterocyclic compounds highly potent as hcv inhibitors
|
EA201290882A1
(ru)
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
ES2608475T3
(es)
|
2010-04-13 |
2017-04-11 |
Celldex Therapeutics, Inc. |
Anticuerpos que se unen a cd27 humana y usos de los mismos
|
MX343410B
(es)
|
2010-07-06 |
2016-11-04 |
Novartis Ag * |
Emulsiones cationicas de agua en aceite.
|
US20140377223A1
(en)
|
2010-07-26 |
2014-12-25 |
Joseph A. Kozlowski |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
US9061041B2
(en)
|
2011-04-13 |
2015-06-23 |
Merck Sharp & Dohme Corp. |
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
WO2012171332A1
(zh)
|
2011-06-16 |
2012-12-20 |
爱博新药研发(上海)有限公司 |
抑制丙型肝炎病毒的大环状杂环化合物及其制备和应用
|
JP6120839B2
(ja)
|
2011-07-06 |
2017-04-26 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
TR201802662T4
(tr)
|
2011-07-06 |
2018-03-21 |
Glaxosmithkline Biologicals Sa |
Nükleik asitler içeren su içinde yağ emülsiyonları.
|
WO2013039876A1
(en)
|
2011-09-14 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
EP2768530A1
(en)
|
2011-10-11 |
2014-08-27 |
Novartis AG |
Recombinant self-replicating polycistronic rna molecules
|
US20180044429A1
(en)
|
2015-03-09 |
2018-02-15 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
US10267803B2
(en)
|
2015-03-27 |
2019-04-23 |
Ortho-Clinical Diagnostics, Inc. |
HCV NS4A/modified NS3 polypeptides and uses thereof
|
EP3313863B1
(en)
|
2015-06-29 |
2020-12-23 |
The Board of Trustees of the Leland Stanford Junior University |
Degron fusion constructs and methods for controlling protein production
|
EA201892362A1
(ru)
|
2016-04-18 |
2019-04-30 |
Селлдекс Терапьютикс, Инк. |
Агонистические антитела, которые связываются с cd40 человека, и варианты их применения
|